Track the 삼성생명 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Banks sector, 삼성생명 has published 79 public disclosures. Market capitalisation: €55,578.4bn. The latest transaction was reported on 24 April 2026 (Other). Among the most active insiders: 박민재. The full history is openly available.
77
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
n/a
14 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 삼성생명 Buy (bullish), based on 18 analysts. Average price target: ₩395,750.
Fundamental score
Ranked 10,903 of 29,062 companies
57.8
score / 100
Value
67
Quality
49
FCF yld9.2%
Earn yld4.1%
EV/EBITDA9.7x
ROE5.3%
Gross mgn·
Net mgn8.1%
Debt/EBITDA2.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Samsung Life es una compañía de seguros surcoreana que ofrece diversos productos de seguros de vida y servicios financieros. Cotiza en la Bolsa de Corea, bajo el símbolo XKRX.